HomeAI · summaries
Storia in 13 fonti
Mid-cap biotechs join Trump’s latest round of drug pricing deals
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Trump reportedly plans to announce new drug pricing deals with nearly a dozen drugmakers
The string of deals builds on the Trump administration's push to link the nation's drug prices to cheaper ones abroad.
- ·
economictimes.indiatimes.com
Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says
Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. …
